GLIMITERIS TRIO 0.3 / 0.2mg Tablet - Uses, Benefits, Dosage, Price & Side Effects

Apr 30, 2024

Discover the comprehensive benefits of GLIMITERIS TRIO 0.3/0.2mg Tablet, a powerful combination of Voglibose 0.3 mg, Glimepiride 3 mg, and Metformin Hydrochloride 500 mg, as we delve into its diverse uses, dosage guidelines, price, and potential side effects. This informative guide aims to provide valuable insights into this medication, empowering you to make informed decisions about your health and well-being.

Understanding GLIMITERIS TRIO 0.3/0.2mg Tablet

GLIMITERIS TRIO 0.3/0.2mg Tablet is a pharmaceutical formulation that combines the therapeutic effects of Voglibose, Glimepiride, and Metformin Hydrochloride. Voglibose is an alpha-glucosidase inhibitor, Glimepiride is a sulfonylurea, and Metformin Hydrochloride is a biguanide antidiabetic agent. This combination medication is designed to improve glycemic control in patients with type 2 diabetes mellitus by targeting multiple pathways involved in glucose regulation.

Uses and Benefits of GLIMITERIS TRIO 0.3/0.2mg Tablet

Healthcare professionals prescribe GLIMITERIS TRIO 0.3/0.2mg Tablet for the management of type 2 diabetes mellitus. This medication helps lower blood sugar levels by inhibiting carbohydrate digestion and absorption (Voglibose), stimulating insulin secretion (Glimepiride), and reducing hepatic glucose production and intestinal glucose absorption (Metformin Hydrochloride). By improving insulin sensitivity and reducing fasting and postprandial glucose levels, GLIMITERIS TRIO 0.3/0.2mg Tablet helps achieve better glycemic control and reduces the risk of diabetes-related complications.

Dosage Guidelines

The dosage of GLIMITERIS TRIO 0.3/0.2mg Tablet may vary depending on individual factors such as the severity of diabetes, renal function, and response to treatment. It is typically taken orally once or twice daily, with meals, to minimize gastrointestinal side effects. The recommended starting dose is usually lower, with gradual dose titration based on glycemic response and tolerability. It's essential to follow the prescribed dosage regimen provided by your healthcare provider to achieve optimal therapeutic outcomes.

Price and Affordability

The price of GLIMITERIS TRIO 0.3/0.2mg Tablet may vary depending on factors such as brand, dosage strength, and location. It's essential to consult with your healthcare provider or pharmacist to obtain accurate pricing information. However, GLIMITERIS TRIO 0.3/0.2mg Tablet offers a cost-effective solution for managing type 2 diabetes mellitus compared to the long-term expenses associated with diabetes-related complications.

Side Effects

While GLIMITERIS TRIO 0.3/0.2mg Tablet is generally well-tolerated, it's important to be aware of potential side effects. Common adverse reactions may include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal discomfort. Additionally, Glimepiride may rarely cause hypoglycemia (low blood sugar levels), while Metformin Hydrochloride may rarely cause lactic acidosis, a serious metabolic complication. It's essential to monitor for signs of hypoglycemia or lactic acidosis and seek medical attention if symptoms occur.

In Conclusion

GLIMITERIS TRIO 0.3/0.2mg Tablet, containing Voglibose, Glimepiride, and Metformin Hydrochloride, offers a comprehensive solution for managing type 2 diabetes mellitus, providing effective glycemic control and reducing the risk of diabetes-related complications. By understanding its uses, benefits, dosage guidelines, price, and potential side effects, individuals can make informed decisions about incorporating this medication into their diabetes treatment plan.

Consulting with a healthcare professional is essential to determine the appropriate dosage, monitor for side effects, and ensure the safe and effective use of GLIMITERIS TRIO 0.3/0.2mg Tablet. Empower yourself with knowledge about this medication and take proactive steps towards better diabetes management and improved overall health. 

A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology.  

 

 For further information: 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com

 CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668

  BUY NOW

 



 

SHARE WITH